Digestive System Carcinoma — Trials

Digestive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7,540 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,123
Recruiting: 1,216
Ph III recruiting: 129
Growth YoY: +14.1%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (884)

clinicaltrialsPublishedShowing 51–59 of 59 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05320692	A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma	active not recruiting	Phase 3	423	Jiangsu HengRui Medicine Co., Ltd.INDUSTRY	1	Dec 11, 2025	clinicaltrials
NCT04669496	Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors	active not recruiting	Phase 2 / Phase 3	178	Shanghai Zhongshan HospitalOTHER	1